Autor der Publikation

Kopieren Löschen Diese Publikation zur Ablage hinzufügen
Community-Eintrag
Versionsverlauf dieses Eintrags
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody

D. Scheim. International Journal of Molecular Sciences, 23 (5): 2558 (Februar 2022)
DOI: 10.3390/ijms23052558

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

David Scheim

Uwe Scheim

David E Hopkins

Kerstin Scheim

Ursula E E Köhler

Weitere Publikationen von Autoren mit dem selben Namen

Rapid increase of SpO2 on room air for 34 severe COVID-19 patients after ivermectin-based combination treatment: 55-62\% normalization within 12-24 hoursJ. Stone, P. Ndarukwa, D. Scheim, B. Dancis, J. Dancis, M. Gill, und C. Aldous. Research Square, (November 2021)SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse EffectsC. Boschi, D. Scheim, A. Bancod, M. Millitello, M. Bideau, P. Colson, J. Fantini, und B. Scola. bioRxiv, (2022)Ivermectin: a multifaceted drug of Nobel prize-honored distinction with indicated efficacy against a new global scourge, COVID-19A. Santin, D. Scheim, P. McCullough, M. Yagisawa, und T. Borody. New Microbes and New Infections, (2021)When Characteristics of Clinical Trials Require Per-Protocol as Well as Intention-to-Treat Outcomes to Draw Reliable Conclusions: Three ExamplesD. Scheim, C. Aldous, B. Osimani, E. Fordham, und W. Hoy. Journal of Clinical Medicine, 12 (11): 3625 (Mai 2023)COVID-19 Excess Deaths in Peru's 25 States in 2020: Nationwide Trends, Confounding Factors, and Correlations With the Extent of Ivermectin Treatment by StateJ. Chamie, J. Hibberd, und D. Scheim. Cureus, (August 2023)Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic ResponsesD. Scheim, P. Parry, D. Rabbolini, C. Aldous, M. Yagisawa, R. Clancy, T. Borody, und W. Hoy. Viruses, (2024)SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse EffectsC. Boschi, D. Scheim, A. Bancod, M. Militello, M. Bideau, P. Colson, J. Fantini, und B. Scola. International Journal of Molecular Sciences, 23 (24): 15480 (Dezember 2022)Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment: 62\% Normalization within 24 HoursJ. Stone, P. Ndarukwa, D. Scheim, B. Dancis, J. Dancis, M. Gill, und C. Aldous. Biologics, 2 (3): 196--210 (August 2022)A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and AntibodyD. Scheim. International Journal of Molecular Sciences, 23 (5): 2558 (Februar 2022)In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds.M. Aminpour, M. Cannariato, J. Preto, M. Safaeeardebili, A. Moracchiato, D. Doria, F. Donato, E. Zizzi, M. Deriu, D. Scheim und 2 andere Autor(en). Comput., 10 (4): 51 (2022)

BibSonomy

Disambiguierung von "Scheim, David E."